CN104000857A - Method for extracting common traditional Chinese medicine from traditional Chinese medicinal materials and authenticating common traditional Chinese medicine through MALDI-TOF-MS - Google Patents

Method for extracting common traditional Chinese medicine from traditional Chinese medicinal materials and authenticating common traditional Chinese medicine through MALDI-TOF-MS Download PDF

Info

Publication number
CN104000857A
CN104000857A CN201410260787.5A CN201410260787A CN104000857A CN 104000857 A CN104000857 A CN 104000857A CN 201410260787 A CN201410260787 A CN 201410260787A CN 104000857 A CN104000857 A CN 104000857A
Authority
CN
China
Prior art keywords
chinese medicine
traditional chinese
crude drug
chinese crude
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410260787.5A
Other languages
Chinese (zh)
Inventor
马伟
胥传来
王文彬
匡华
徐丽广
刘丽强
宋珊珊
吴晓玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201410260787.5A priority Critical patent/CN104000857A/en
Publication of CN104000857A publication Critical patent/CN104000857A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a method for extracting a common traditional Chinese medicine from traditional Chinese medicinal materials and authenticating the common traditional Chinese medicine through MALDI-TOF-MS, and belongs to the technical field of biology. According to the method, the traditional Chinese medicinal materials are smashed at high speed, total protein and polypeptide are extracted from the traditional Chinese medicinal materials, dialysis desalination is conducted, then the MALDI-TOF-MS is adopted for detection, and a traditional Chinese medicinal material protein map is obtained. The simple protein extracting technology and Malditof are combined for authenticating the protein maps of the common traditional Chinese medicinal materials such as astragalus membranaceus, ginseng and liquorice. The method has the advantages of being easy and reliable to implement, and provides selections and references for authenticating the common traditional Chinese medicinal materials.

Description

A kind of conventional Chinese medicine method with MALDI-TOF-MS qualification extracted from Chinese crude drug
Technical field
The present invention relates to a kind of conventional Chinese medicine method with MALDI-TOF-MS qualification extracted from Chinese crude drug, be specifically related to a kind of method of the Malditof of application qualification parts of generic medicinal plants Radix Astragali, Radix Ginseng, Radix Glycyrrhizae, belong to biological technical field.
Background technology
Chinese crude drug is the raw material of the prepared slices of Chinese crude drugs, Chinese medicine extract and Chinese patent medicine, and its front end is medicinal plants, medicinal animal, mineral drug and specific medicinal part thereof, or it is former to be called the base of Chinese crude drug.The precise Identification of Chinese crude drug is the basic link of Chinese medicine operation and development, receives much concern always.The species confirmation of originate of the relevant medical material standard Main Basis means of taxonomic research of country, defines medicinal part, has substantially clarified confusion.But medical material market is in dynamic change, there is fake and forged phenomenon in some important drugs resources, and the simultaneously former variation of base and new medical material type constantly occur, the Chinese crude drug in the different places of production there are differences, and identification research work still can not be relaxed.
Along with going deep into and scientific and technical development of Chinese medicine research, existing several classes are for the identification of the new technique of Chinese crude drug at present.The first kind is chemical identification technology.The material base of Chemistry for Chinese Traditional Medicine qualification is its contained chemical composition group.Chinese crude drug ingredient complexity is various, and chemical identification is selected the chemical composition of minority tool feature conventionally, or forms feature as appraisal basis using the entirety of chemical composition.Along with the development of chromatographic isolation, analytical technology, HPLC, GC, the methods such as HPCE and with the development of spectrum multiple techniques, can reflect meticulousr and exactly the features such as Chinese crude drug chemical group mark and amount, become the effective ways of Materia Medica Identification and quality control.Equations of The Second Kind is Molecular Identification technology.Mainly to identify for DNA molecular and protein.DNA bar codes technique based on sequence analysis is that impact is at present large, application DNA authenticate technology more widely.Compared with other method for identifying molecules, the qualification of DNA bar code has three advantages: qualification result is repeatable good; Method highly versatile; Can build unified database and qualification platform, be easy to promote and standardization.
Mainly contain protein electrophorese technology, ELISA detection technique, albumen flight time mass spectrum authenticate technology for the authenticate technology of albumen.Substance assistant laser desorpted ionized flight time mass spectrum (Matrix-assisted laser desorption ionization-time of flight massspectrometry, MALDI-TOF-MS) technology is the novel organic mass spectrometry of a kind of soft ionization that development in recent years is got up, by introducing substrate molecule, make testing molecule not produce fragment, solved non-volatile and problem thermal instability biomacromolecule desorption ionization.The features such as that MALDI-TOF-MS has is highly sensitive, accuracy is high, resolution is high, collection of illustrative plates is simple and clear, mass range is wide and speed is fast, have special superiority measuring polypeptide, protein and synthetic high polymer application aspect.
At present MALDI-TOF-MS has obtained comparatively successfully application aspect microbial identification, but application aspect Materia Medica Identification is also relatively less.Chinese crude drug also has more protein component, and the composition of the Chinese crude drug of same breed more existing conservatives on albumen composition also has the heterogeneity of the impact such as the factor that is subject to the place of production.Therefore applying the mass spectrum that MALDI-TOF-MS collects the Chinese crude drug in the different places of production of different Chinese crude drugs, same breed not only can evaluate but also can be for the identification of Chinese crude drug.The present invention's application Protein Extraction technology has been collected the mass spectrum of the common Chinese medicine material Radix Astragali, Radix Glycyrrhizae, Radix Ginseng in conjunction with sample treatment application MALDI-TOF-MS, for its qualification provides selection and reference.
Summary of the invention
The object of the invention is to set up a kind of method of identifying the parts of generic medicinal plants Radix Astragali, Radix Ginseng, Radix Glycyrrhizae, for identifying that conventional Chinese crude drug provides selection and reference.
Technical scheme of the present invention, the present invention carries out high speed pulverization and has extracted Chinese crude drug total protein and polypeptide Chinese crude drug, after dialysis desalination, detects and has obtained Chinese crude drug protein profiling with MALDI-TOF-MS.
A kind of method of extracting conventional Chinese medicine from Chinese crude drug, step is: get traditional Chinese medicinal material samples and pulverize through vertical and high-speed pulverizer, then getting 4g powder sample uses containing 50mM NaCl, pH 8.0 25mM Tris-HCl buffer and dissolves according to the mass volume ratio example of 1:10,50 DEG C of water-bath lixiviate 4h; The centrifugal 30min of 8000 rpm, gets supernatant subsequently, with 15mL centrifugal ultrafiltration pipe concentrating sample be 1mL to volume, it blocks molecular weight is 3KD, pure water dialysis 2 days for sample obtains total protein and the polypeptide of conventional Chinese medicine in Chinese crude drug.
Described conventional Chinese medicine is the Radix Astragali, Radix Ginseng or Radix Glycyrrhizae.
The method of Malditof qualification for the described conventional Chinese medicine extracting from Chinese crude drug, step is: will in Chinese crude drug, extract the total protein of conventional Chinese medicine and polypeptide according to the upper quadrat method loading of conventional albumen, get 1 μ L point on Malditof target, cover on sample Deng getting 1 μ L TA substrate liquid after its natural drying, sample detection after natural drying, obtains the collection of illustrative plates of conventional Chinese medicine.
Beneficial effect of the present invention: the method for the application Malditof qualification parts of generic medicinal plants Radix Astragali provided by the invention, Radix Ginseng, Radix Glycyrrhizae, adopt high speed pulverization method Chinese crude drug to be processed to and extracted in conjunction with simple solution leach extraction method total protein and the polypeptide of Chinese crude drug, after dialysis, be the collection of illustrative plates that available Malditof obtains the proteins and peptides of sample, and then realize the qualification to Chinese crude drug.Have compared with other method simple to operate, analysis time is short, the feature of method highly versatile; With similar unified database and the qualification platform of building of DNA bar codes technique, be easy to promote and standardization.
Brief description of the drawings
The Malditof mass spectrum of the Radix Astragali of Fig. 1-a Inner Mongol.
The Malditof mass spectrum of the Radix Astragali in Fig. 1-b Suzhou.
The Malditof mass spectrum of the Radix Astragali in Fig. 1-c Gansu.
The Malditof mass spectrum of the Radix Glycyrrhizae of Fig. 2-a Inner Mongol.
The Malditof mass spectrum of the west of Gansu Province, Fig. 2-b Gansu Radix Glycyrrhizae.
The Malditof mass spectrum of the Radix Glycyrrhizae in Fig. 2-c Xinjiang.
The Malditof mass spectrum of Fig. 3-a northeast Radix Ginseng.
The Malditof mass spectrum of Fig. 3-b American Ginseng.
Detailed description of the invention
Further illustrate by the following examples the present invention.
Embodiment 1
Instrument:
Substance assistant laser desorpted ionized flight time mass spectrum (ultrafle Xtreme MALDI-TOF-MS), German Brooker ;
YS-04 miniature high-speed pulverizer, the Yanshan Mountain, Beijing Zheng De plant equipment company limited;
70mm (MD77) bag filter, Cutoff is 3KDa, USA;
TGL-40B table-type low-speed centrifuge, Anting Scientific Instrument Factory, Shanghai;
KFLOW water purification machine, Kai Folong company;
The horizontal shaking table of ZD-9556, granary science and education equipment factory;
Adjustable pipettor, Thermo Labsystems company;
Turbine mixer, Shanghai Hu Xi Instrumental Analysis factory.
Two, reagent: Tris base, Sigma-Aldrich; Other reagent are analytical reagent.
Three, step, taking Chinese medicine astragalus as example
1, traditional Chinese medicinal material samples is processed and Protein Extraction
Get the dry Radix Astragali after 15g section, pulverize through vertical and high-speed pulverizer.Getting 4g powder sample uses containing 50mM NaCl, pH 8.0 25mM Tris-HCl buffer and dissolves according to the mass volume ratio example of 1:10,50 DEG C of water-bath lixiviate 4h.The centrifugal 30min of 8000 rpm, gets supernatant, and using 15mL centrifugal ultrafiltration pipe (millipore, blocking molecular weight is 3KDa) concentrating sample is 1mL to volume.Pure water dialysis (blocking molecular weight is 3KD) dialysis 2 days for sample, removes salt ion, obtains total protein and the polypeptide of the Radix Astragali.
2, Malditof qualification parts of generic medicinal plants
By the total protein of the conventional Chinese medicine extracting in Chinese crude drug and polypeptide according to the upper quadrat method loading of conventional albumen, get 1 μ L point on Malditof target, cover on sample Deng getting 1 μ L TA substrate liquid after its natural drying, sample detection after natural drying, obtains the collection of illustrative plates of conventional Chinese medicine.
Put forward after total protein and polypeptide the Malditof mass spectrum of the Radix Astragali of identifying the Inner Mongol, Suzhou and the Gansu that obtain with Malditof respectively as shown in Fig. 1-a, Fig. 1-b and Fig. 1-c according to above-mentioned steps; The Malditof mass spectrum of the Radix Glycyrrhizae in Inner Mongol, the west of Gansu Province, Gansu and Xinjiang is as shown in Fig. 2-a, Fig. 2-b and Fig. 2-c; The Malditof mass spectrum of the Radix Ginseng of northeast and the U.S. is as shown in Fig. 3-a and Fig. 3-b.

Claims (3)

1. one kind is extracted the method for conventional Chinese medicine from Chinese crude drug, it is characterized in that step is: get traditional Chinese medicinal material samples and pulverize through vertical and high-speed pulverizer, then getting 4g powder sample uses containing 50mM NaCl, pH 8.0 25mM Tris-HCl buffer and dissolves according to the mass volume ratio example of 1:10,50 DEG C of water-bath lixiviate 4h; The centrifugal 30min of 8000 rpm, gets supernatant subsequently, with 15mL centrifugal ultrafiltration pipe concentrating sample be 1mL to volume, it blocks molecular weight is 3KD, pure water dialysis 2 days for sample obtains total protein and the polypeptide of conventional Chinese medicine in Chinese crude drug.
2. the method for extracting according to claim 1 conventional Chinese medicine from Chinese crude drug, is characterized in that: described conventional Chinese medicine is the Radix Astragali, Radix Ginseng or Radix Glycyrrhizae.
3. the method for Malditof qualification for the conventional Chinese medicine that described in claim 1, method is extracted from Chinese crude drug, it is characterized in that step is: will in Chinese crude drug, extract the total protein of conventional Chinese medicine and polypeptide according to the upper quadrat method loading of conventional albumen, get 1 μ L point on Malditof target, cover on sample Deng getting 1 μ L TA substrate liquid after its natural drying, sample detection after natural drying, obtains the collection of illustrative plates of conventional Chinese medicine.
CN201410260787.5A 2014-06-13 2014-06-13 Method for extracting common traditional Chinese medicine from traditional Chinese medicinal materials and authenticating common traditional Chinese medicine through MALDI-TOF-MS Pending CN104000857A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410260787.5A CN104000857A (en) 2014-06-13 2014-06-13 Method for extracting common traditional Chinese medicine from traditional Chinese medicinal materials and authenticating common traditional Chinese medicine through MALDI-TOF-MS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410260787.5A CN104000857A (en) 2014-06-13 2014-06-13 Method for extracting common traditional Chinese medicine from traditional Chinese medicinal materials and authenticating common traditional Chinese medicine through MALDI-TOF-MS

Publications (1)

Publication Number Publication Date
CN104000857A true CN104000857A (en) 2014-08-27

Family

ID=51361946

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410260787.5A Pending CN104000857A (en) 2014-06-13 2014-06-13 Method for extracting common traditional Chinese medicine from traditional Chinese medicinal materials and authenticating common traditional Chinese medicine through MALDI-TOF-MS

Country Status (1)

Country Link
CN (1) CN104000857A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105574474A (en) * 2014-10-14 2016-05-11 中国科学院大连化学物理研究所 Mass spectrometry information-based biological characteristic image identification method
CN105572212A (en) * 2014-10-14 2016-05-11 中国科学院大连化学物理研究所 Visual mass spectrometry information-based sun-dried ginseng and red ginseng rapid identification method
CN110596230A (en) * 2019-09-18 2019-12-20 山东省分析测试中心 MALDI-TOF-MS-based high-throughput analysis method for capsule single-particle medicine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1687115A (en) * 2005-03-25 2005-10-26 中国农业大学 Agglutinin protein of astragalus root and preparation method thereof
CN102260340A (en) * 2011-06-20 2011-11-30 长春中医药大学 Chinese magnoliavine protein, and preparation method and medicinal application thereof
CN103627699A (en) * 2012-08-21 2014-03-12 中国中医科学院中药研究所 Traditional Chinese medicinal material genome DNA extraction method suitable for DNA amplification technology

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1687115A (en) * 2005-03-25 2005-10-26 中国农业大学 Agglutinin protein of astragalus root and preparation method thereof
CN102260340A (en) * 2011-06-20 2011-11-30 长春中医药大学 Chinese magnoliavine protein, and preparation method and medicinal application thereof
CN103627699A (en) * 2012-08-21 2014-03-12 中国中医科学院中药研究所 Traditional Chinese medicinal material genome DNA extraction method suitable for DNA amplification technology

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
唐根源等: "中药黄芪蛋白成分的分离和分析", 《福建分析测试》 *
张志斐等: "枸杞子多肽的MALDI-TOF-MS定性分析", 《中草药》 *
王兆伏等: "质谱技术在中药小分子与生物大分子相互作用研究中的应用", 《质谱学报》 *
袁湘林等: "基体辅助激光解吸电离飞行时间质谱用于中草药黄芪鉴别的研究", 《药物分析杂志》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105574474A (en) * 2014-10-14 2016-05-11 中国科学院大连化学物理研究所 Mass spectrometry information-based biological characteristic image identification method
CN105572212A (en) * 2014-10-14 2016-05-11 中国科学院大连化学物理研究所 Visual mass spectrometry information-based sun-dried ginseng and red ginseng rapid identification method
CN105574474B (en) * 2014-10-14 2019-03-12 中国科学院大连化学物理研究所 A kind of biometric image recognition methods based on Information in Mass Spectra
CN110596230A (en) * 2019-09-18 2019-12-20 山东省分析测试中心 MALDI-TOF-MS-based high-throughput analysis method for capsule single-particle medicine

Similar Documents

Publication Publication Date Title
CN102579612B (en) Method for extracting total alkaloid of aconitum soongaricum
CN104000857A (en) Method for extracting common traditional Chinese medicine from traditional Chinese medicinal materials and authenticating common traditional Chinese medicine through MALDI-TOF-MS
CN106770839B (en) The extraction detection method of flavone compound in a kind of subprostrate sophora
CN105572284B (en) A kind of quick detection and the analysis method for identifying chemical composition in elegant jessamine
CN106198832A (en) A kind of quality of production control method of intensified loquet distillate
Gao et al. Analysis of protoberberine alkaloids in several herbal drugs and related medicinal preparations by non‐aqueous capillary electrophoresis
CN103175924B (en) Novel method for simultaneously measuring contents of multiple active ingredients of dogwood
CN102967670A (en) Method for measuring cordycepin, adenosine and mannitol in cordyceps sinensis mycelium powder
CN103344717B (en) Method for establishing rhizoma bletillae high performance liquid chromatography (HPLC) fingerprint spectrum and standard fingerprint spectrum thereof
CN110658295B (en) Method for measuring fingerprint spectrum of lotus leaf decoction pieces in Erdong decoction formula
CN104931592A (en) Content detection method of 14 non-volatile components in dragon tiger Rendan mini-pill vegetable drug
CN104007220B (en) A kind of method simultaneously detecting compound red beach wormwood sheet principal ingredient in blood plasma
CN104634885B (en) A kind of Analysis and Identification method of flavones ingredient in Callicarpa nudiflora
CN115406997A (en) Folium artemisiae argyi quality detection method based on HPLC fingerprint
CN102628838B (en) Fujian herb cusia HPLC fingerprint construction method
CN104849382A (en) Rapid analysis method of unknown sesquiterpenes pyridine alkaloids in thunder god vine
CN104535513A (en) Glabrous sarcandra herb extract and detection method of preparation thereof
CN104569195A (en) Method for detecting content of flavonoid active ingredients in toothpaste containing traditional Chinese medicine baical skullcap roots
CN107102087A (en) A kind of method of a variety of organic acid contents in chromatography of ions detection coptis
CN106526043A (en) RRLC-Q-TOF-MS method for detecting diversified chemical components in leaves of tetrastigma hemsleyanum diels et gilg
CN105037311A (en) Apigenin on-line two-dimensional composite liquid-phase extraction purification method
CN104931616A (en) Mangnolia officinalis content assaying method for ageratum liquid
CN104133028A (en) Establishment method for high performance liquid chromatography fingerprint of Rubia cordifolia root formula granule and standard fingerprint thereof
CN104744260A (en) Method for separating polyphenol monomer from canavalia maritime by adopting high-speed countercurrent chromatography
CN1588049A (en) Method for producing Chinese medicine fingerprint atlas

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140827

WD01 Invention patent application deemed withdrawn after publication